Group 1 - The company, Beilu Pharmaceutical, plans to issue shares to no more than 35 specific investors through a simplified procedure for the year 2025 [1] - The issuance price will not be lower than 80% of the average trading price of the company's shares over the 20 trading days prior to the pricing benchmark [1] - The total amount of funds raised from this issuance will not exceed 300 million yuan, and the net proceeds will be fully invested in specific projects including the construction of a production workshop and intelligent warehouse for LZB pharmaceutical [1] Group 2 - The issuance will not exceed 30% of the company's total share capital prior to this issuance [1] - The funds will also be allocated to the technical transformation projects for the production lines of 100 tons of Iodinated Methylpyrrolidone and 50 tons of Iodinated Butanol [1] - Additionally, part of the funds will be used to supplement working capital [1]